ClinicalTrials.Veeva

Find clinical trials for Non-Small-Cell Lung Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near Kansas City, KS, USA:

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: encorafenib
Drug: binimetinib

Phase 2

Pfizer
Pfizer

Kansas City, Missouri, United States and 158 other locations

participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC)....

Enrolling
Stage III Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer
Biological: IOV-4001

Phase 1, Phase 2

Iovance Biotherapeutics

Westwood, Kansas, United States and 7 other locations

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...

Active, not recruiting
Advanced Non Small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Drug: Docetaxel
Drug: MRTX849

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Westwood, Kansas, United States and 227 other locations

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Phase 2

AbbVie
AbbVie

Kansas City, Kansas, United States and 252 other locations

Locations recently updated

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...

Enrolling
Non Small Cell Lung Cancer
Biological: Telisotuzumab Vedotin
Drug: Docetaxel

Phase 3

AbbVie
AbbVie

Kansas City, Missouri, United States and 258 other locations

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

Kansas City, Kansas, United States and 152 other locations

provides improved patient outcomes compared to pembrolizumab alone in patients with previously treated locally advanced or metastatic non-sm ...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: Placebo
Drug: CC-486

Phase 2

Celgene
Celgene

Kansas City, Missouri, United States and 32 other locations

Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) t...

Enrolling
Non-small Cell Lung Cancer
Drug: SBRT
Drug: Alectinib

Phase 2

Genentech
Genentech

Kansas City, Missouri, United States and 32 other locations

with locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC), excl...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Atezolizumab
Drug: Tiragolumab

Phase 2

Genentech
Genentech

Kansas City, Missouri, United States and 40 other locations

in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...

Enrolling
Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Drug: furmonertinib 240 mg oral, daily
Drug: furmonertinib 160 mg oral, daily

Phase 3

ArriVent BioPharma
ArriVent BioPharma

Kansas City, Missouri, United States and 189 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems